Clinical significance soluble antigen sera patients untreated Hodgkin disease soluble form antigen glycoprotein Hodgkin's-derived cell lines vitro patients Hodgkin lymphoma adult T-cell leukemia rare cases non-Hodgkin lymphoma infectious mononucleosis anti-EBV-IgM+ prospective study consecutive untreated patients Hodgkin disease protocols German Hodgkin Study group detectable levels serum patients symptoms maximum levels U/mL stage IVB patients evaluable response patients rates complete remission rates progressive disease patients freedom treatment failure curves patients successful treatment patients progressive disease patients complete remission healthy controls valuable marker disease activity prognostic significance Hodgkin disease 